Uploaded videos
1-10 of 515-
Dr. Steensma Discusses Iron Chelation Therapy for MDS
OncLiveTV
6 views
David P. Steensma, MD, attending physician, hematologic oncology, Dana-Farber Cancer Institute, Boston, MA, discusses the arguments against the use of iron chelation in pat...
-
Dr. Erba Describes Proper Diagnostic Testing of CML
OncLiveTV
2 views
Harry Erba, MD, PhD, associate professor, Department of Internal Medicine, University of Michigan Health System, discusses the full histopathological examination that shoul...
-
Dr. Ansell Describes Waldenström Macroglobulinemia
OncLiveTV
35 views
Stephen Ansell, MD, PhD, professor of medicine at the Mayo Clinic in Minnesota, explains the 2 main types of patients with Waldenström Macroglobulinemia (WM), a rare type o...
-
Dr. Dunleavy Discusses 3 Molecular Subtypes of DLBCL
OncLiveTV
35 views
Kieron Dunleavy, MD, a staff clinician with the National Cancer Institute in Bethesda, MD, discusses the changes that have occurred in the understanding of diffuse large B-...
-
Dr. Burris Discusses Recurrence Scores Predicting pCR
OncLiveTV
16 views
Howard A. "Skip" Burris, III, MD, chief medical officer and executive director, Drug Development Program, Sarah Cannon Research Institute in Nashville, Tennessee, discusses...
-
Dr. Perez Discusses Optimizing Adjuvant Therapy
OncLiveTV
19 views
Edith A. Perez, MD, deputy director, Mayo Clinic Cancer Center, Florida, director, Breast Program, Serene M. and Frances C. Durling Professor of Medicine, Mayo Medical Scho...
-
Dr. Schnabel on Predicting Breast Cancer by Atypia Type
OncLiveTV
24 views
Freya R. Schnabel, MD, Professor of Surgery, NYU School of Medicine, summarizes information presented at the 2011 San Antonio Breast Cancer Symposium that discussed the ris...
-
Dr. Leyland-Jones Discusses Genome Sequencing
OncLiveTV
11 views
Brian Leyland-Jones, MD, PhD, Director, Winship Cancer Institute, Emory University, discusses the use of whole-genome sequencing, describing that the cost has recently redu...
-
Dr. Harvey on Aromatase Inhibitor Treatment Duration
OncLiveTV
28 views
Harold A. Harvey, MD, Professor of Medicine, Director, Hematology/Oncology Fellowship Program, Penn State Hershey Cancer Institute, discusses the optimal duration of treatm...
-
Dr. Bloom Explains Situations Requiring HER2 Retesting
OncLiveTV
45 views
Kenneth J. Bloom, MD, Chief Medical Officer, Clarient, discusses retesting patients who present with HER2-positive characteristics but receive HER2-negative test results.
...
Advertisement










Play all(515)